top of page

Title: Australia stocks higher at close of trade; S&P/ASX 200 up 0.09%

Writer: analysiswatchanalysiswatch

Jun 16, 2021 03:45AM ET

By: AnalysisWatch

Australia shares had been better after the near on Wednesday, as profits the Energy, Financials and Utilities sectors led stocks better.

At the near in Sydney, the S&P/ASX 2 hundred won 0.09% to hit a brand new all-time high.

The exceptional performers of the consultation at the S&P/ASX 2 hundred had been Pro Medicus Ltd (ASX: PME), which rose 3.62% or 1.86 factors to alternate at 53.22 on the near. Meanwhile, Ingenia Communities Group (ASX: INA) brought 2.87% or 0.17 factors to cease at 6.09 and Washington H Soul Pattinson&Co Ltd (ASX:SOL) changed into up 2.78% or 0.87 factors to 32.15 in past due alternate.

The worst performers of the consultation had been OZ Minerals Ltd (ASX: OZL), which fell 6.69% or 1.71 factors to alternate at 23.85 on the near. Nuix Ltd (ASX: NXL) declined 5.80% or 0.16factors to cease at 2.60 and Clinuvel Pharmaceuticals Ltd (ASX: CUV) changed into down 5.66% or 1.62 factors to 26.98.

Falling shares outnumbered advancing ones at the Sydney Stock Exchange through 900 to 485 and 396 ended unchanged.

Shares in Pro Medicus Ltd (ASX: PME) rose to all-time highs; growing 3.62% or 1.86 to 53.22. Shares in Ingenia Communities Group (ASX: INA) rose to 5-12 months’ highs; up 2.87% or 0.17 to 6.09.

The S&P/ASX 2 hundred VIX, which measures the implied volatility of S&P/ASX 2 hundred options, changed into down 4.78% to 11.604.



 
 
 

Kommentare


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page